Mayumi Fujita, MD, PhD, says she is not someone who has had a straightforward path for her career or her life ..read more

As senior associate athletic director for health and performance at the University of Colorado Boulder, Miguel Rueda is used to overseeing the wellness of student-athletes in sports ranging from football and basketball to golf, skiing, and lacrosse.  ..read more

Despite being the leading cause of cancer-related death worldwide, Nina Thomas, MD, shares that lung cancer has a significantly lower screening rate compared to other common cancers. Various barriers, including lack of awareness, misconceptions, geographic and socioeconomic disparities, and stigma surrounding smoking, contribute to this low rate. Lung cancer screening, recommended for high-risk individuals, involves a low-dose CT scan that is quick, non-invasive, and effective in detecting early-stage cancer. Efforts to improve screening rates focus on public education, reducing disparities, a ..read more

Two years after her lung cancer diagnosis in 2019, Dan Wu first came to D. Ross Camidge, MD, PhD, at the University of Colorado Cancer Center for a second opinion.  “Dr. Camidge saved my life,” Wu said ..read more

Bradley R. Corr, MD, explores the rationale and results of a phase 2 trial comparing rucaparib to placebo as maintenance therapy for metastatic and recurrent endometrial cancer. Discover the significant progression-free survival improvements and implications for patients in this insightful discussion ..read more

In all medical research, but particularly in cancer research, clinical trials save lives. They test the great new discoveries that can combat cancer, and the only way we're going to get better at preventing, diagnosing, and treating cancer is to put our best drugs and techniques forward and test them ..read more

Why do some lung cancer patients respond better to the types of drugs known as tyrosine kinase inhibitors? It may have to do with those patients’ own immune systems ..read more

In the realm of cancer research, clinical trials can lead to more effective drugs, better treatments, and ways to prevent and detect cancer. They are a key step in the journey from scientific discoveries to helping current and future patients. Clinical trials are a major factor behind a 33% drop in the U.S. cancer death rate and an estimated 3.8 million cancer deaths avoided over the last four decades ..read more

For Enrique Soto Pérez de Celis, treating cancer globally starts with treating cancer locally ..read more

All women need to pay attention to their risk factors for breast cancer and ovarian cancer, but women of Eastern European (Ashkenazi) Jewish ancestry should be especially vigilant, says University of Colorado Cancer Center member Marie Wood, MD, as their risk for having a genetic variant in the BRCA1 or BRCA2 genes is increased, predisposing them to developing hereditary breast and ovarian cancer ..read more